Tempus AI to Acquire Personalis in $1.5 Billion Deal: AI and Cancer Testing Come Together
Tempus AI has agreed to acquire Personalis in a transaction valued at approximately $1.5 billion, net of Tempus…
Novartis’ $1.5 Billion Myricx Bio Acquisition: A New Era in Cancer Treatment
Swiss pharmaceutical giant Novartis has agreed to acquire UK-based biotechnology company Myricx Bio in a deal worth up…

































































